HKG Equity Snapshot
1877 Weekly Equity Report
Shanghai Junshi Biosciences Co., Ltd.
What the company does
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China. The company's product pipelines include Tifcemalimab, an anti- B and T lymphocyte attenuator mAB which is in phase III clinical trial to treat lung cancer and lymphocyte; Roconkibart, an anti-interleukin-17A monoclonal antibody which is in phase III clinical trial to treat psoriatic and spondylitis; JS001sc, a subcutaneous injection which is in phase III clinical trial for the treatment of tumors; JS105, an oral small molecule inhibitor targeting PI3K-a which is in phase III clinical trial …
What the weekly tape is saying
1877 closed the latest completed week at 17.29 HKD. The 4-week return is -27.1% and the 12-week return is -21.1%. Trend Signal is inactive, Market Dynamics is -0.37. Setup signature: Risk-first tape with a 15/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 22.86 HKD
- Vs Trend Line
- -24.4%
- Fair Value
- 18.50 HKD
- Vs Fair Value
- -6.6%
- 52W High
- 38.64 HKD
- 52W Low
- 15.74 HKD
- Drawdown
- -55.3%
- Range Position
- 6.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 22
- 52W Active Breadth
- 42.3%
- Sector Scope
- HK Healthcare
- Sector Rank
- 89 of 257
- Sector Percentile
- 65.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 92 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 63 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.37
- 4W MD Change
- -145.9%
- Relative Strength
- -27.86
- 4W RS Change
- -326.7%
- Expectation
- Undecided
- Probability
- 46.42%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 16.7M
- 13W Average
- 20.1M
- 52W Average
- 30.7M
- Vs 13W
- 0.8x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.8%
- 52W Volatility
- 8.6%
- Upside Weeks
- 22
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 7.8% / -6.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 19.9B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 17.29 HKD | 0.2% | 22.86 HKD | 18.50 HKD | -0.37 | -27.86 | 16.7M | Off |
| 5 Jun 2026 | 17.26 HKD | -18.0% | 23.14 HKD | 18.55 HKD | 0.01 | -29.21 | 27.3M | Off |
| 29 May 2026 | 21.06 HKD | -9.1% | 23.38 HKD | 18.61 HKD | 0.27 | -14.73 | 15.9M | Off |
| 22 May 2026 | 23.16 HKD | -2.4% | 23.57 HKD | 18.63 HKD | 0.57 | -7.83 | 12.9M | Off |
| 15 May 2026 | 23.72 HKD | -3.1% | 23.63 HKD | 18.66 HKD | 0.81 | -6.53 | 17.1M | Off |
| 8 May 2026 | 24.48 HKD | -7.0% | 23.72 HKD | 18.68 HKD | 1.04 | -4.59 | 10.0M | Off |
| 1 May 2026 | 26.32 HKD | 1.7% | 23.89 HKD | 18.70 HKD | 1.12 | 5.62 | 17.1M | Off |
| 24 Apr 2026 | 25.88 HKD | -10.6% | 24.07 HKD | 18.72 HKD | 1.20 | 3.67 | 28.2M | Off |
| 17 Apr 2026 | 28.96 HKD | 16.1% | 24.20 HKD | 18.75 HKD | 0.99 | 15.88 | 33.7M | Off |
| 10 Apr 2026 | 24.94 HKD | -5.5% | 24.30 HKD | 18.77 HKD | 0.64 | 1.73 | 15.0M | Off |
| 3 Apr 2026 | 26.38 HKD | 17.0% | 24.60 HKD | 18.81 HKD | 0.22 | 11.59 | 29.0M | Off |
| 27 Mar 2026 | 22.54 HKD | 2.9% | 24.87 HKD | 18.84 HKD | -0.35 | -3.35 | 14.8M | Off |
| 20 Mar 2026 | 21.90 HKD | 9.2% | 25.15 HKD | 18.87 HKD | -0.63 | -6.83 | 23.9M | Off |
| 13 Mar 2026 | 20.06 HKD | 3.8% | 25.56 HKD | 18.91 HKD | -0.85 | -14.84 | 11.3M | Off |